Videos
Analyzing Pharmacy Benefits in Value-Based Oncology Pathways
10/14/2022
James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways Congress.
Current Issue
October 2024
Volume 10
Issue 5
Subscribe
Journal of Clinical Pathways Newsletter